The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
Open accessAbstract
A PAMless base editor: CRISPR-Cas DNA base editing typically requires a specific motif for targeting known as a protospacer-adjacent motif (PAM). This requirement limits the sequences within a genome that can be targeted. Walton et al. engineered specific variants of the Streptococcus pyogenes Cas9 enzyme named SpG and SpRY that could recognize and edit a wider array of PAMs. Using SpRY, the authors were able to correct previously uneditable mutations associated with human disease. Although off-target effects were observed for these engineered Cas enzymes at levels similar to those of the wild-type enzyme, depending on the context, these engineered enzymes widen the potential applications of precision genome editing. Science , this issue p. 290
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Efforts are ongoing to develop PAM-free Cas9 molecules to eliminate PAM site constraints altogether, thereby increasing the flexibility and effectiveness of genome editingthrough structure-based rational engineering or by altering amino acid substitutions in the PAM-interacting domain (Walton et al., 2020).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Walton et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas dominates the field because of the ease of using guide RNAs directing the CRISPR complex to specific DNA sequences and the increasing ability to target most sites in the genome.121,122”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [122]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Building on this, Walton et al. (2020) introduced the SpG variant, which can recognize a broader range of NGN PAMs.”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Walton et al., 2020
The cited source says what the claim attributes to it.
In the citing paper
“These can be targeted in combination with evolved Cas9 variants such as SpCas9-NG20 or SpG.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“These can be targeted with SpRY.19”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 genomic localization is delimited by the protospacer adjacent motif (PAM), which is NGG for SpCas9 while evolved variants of SpCas9 tolerate a broader range of PAM sequences17–21.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Self-citationRNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,002
Jeong, Y. Y., Han, J. H., Yu, J., Bae, S., & Seo, P. J. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0102 · Cited by 4
Visualization of a multi-turnover Cas9 after product release
Kiernan, K. A., & Taylor, D. W. (2025) · Nature Communications · doi:10.1038/s41467-025-60668-7 · Cited by 4
Yu, M., Ai, L., Wang, B., Lian, S., Ip, L., Liu, J., Li, L. X., Tsai, S. Q., Kleinstiver, B. P., & Zheng, Z. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01464-y · Cited by 5
Self-citationHe, Z., Xie, Y., Huang, H., Zhang, Z., Feng, S., Xu, R., Chen, X., Gao, F., Li, P., Zhu, M., et al. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.08.003 · Cited by 4
Gene therapy for inborn errors of immunity: past progress, current status and future directions
Torrance, R. W., Orf, K., & Fox, T. A. (2025) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2025.42 · Cited by 5
Elsayed, E., Stukenberg, D., Meier, D., Schmeck, B., & Becker, A. (2025) · Communications Biology · doi:10.1038/s42003-025-08934-8 · Cited by 4
Zhang, R., Tang, X., He, Y., Wang, W., Ren, Q., Qi, Y., & Zhang, Y. (2026) · Journal of Integrative Plant Biology · doi:10.1111/jipb.70155 · Cited by 4
Ablation of PKCα Phosphorylation by CRISPR-Cas9 Base Editing Rescues Heart Failure
Tadokoro, T., Li, H., Gan, P., Xu, Z., Tan, W. H., Alzhanov, D., Sanchez‐Ortiz, E., McAnally, J., Guo, L. M., Xu, L., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.326738 · Cited by 4
Application and Research Prospects of CRISPR/Cas Gene Editing Technology in Lactic Acid Bacteria
张二红, Yan, J., Du, J., Chu, X., & Chen, D. (2026) · Microorganisms · doi:10.3390/microorganisms14040739 · Cited by 4
Mengistu, G. (2026) · The Journal of Gene Medicine · doi:10.1002/jgm.70091 · Cited by 4
Cho, S. W., Kim, T.-H., Yang, J., Byun, G., & Seo, S. W. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag422 · Cited by 4
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics
Grigg, S. E., Shembrey, C., Fareh, M., Blombery, P. A., Corn, J. E., Seymour, J. F., & Casan, J. M. L. (2026) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-026-01179-2 · Cited by 4
LMNA Co-Regulated Gene Expression as a Suitable Readout after Precise Gene Correction
Wang, H., Krause, A., Escobar, H., Müthel, S., Metzler, E., & Spuler, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415525 · Cited by 4
Salmonella - Perspectives for Low-Cost Prevention, Control and Treatment
Huang, H., & Naushad, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102150 · Cited by 4
Mary, L., Leclerc, D., Labalme, A., Bellaud, P., Mazaud‐Guittot, S., Dréano, S., Evrard, B., Bigand, A., Cauchoix, A., Loget, P., et al. (2023) · Genes · doi:10.3390/genes14020273 · Cited by 4
Transcriptional Regulation Technology for Gene Perturbation in Fission Yeast
Ishikawa, K., & Saitoh, S. (2023) · Biomolecules · doi:10.3390/biom13040716 · Cited by 4
Undetectable off-target effects induced by FokI catalytic domain in mouse embryos
Xie, L., Hu, F., Li, Z., Li, D., Yang, X., Yuan, T., Yan, N., He, C., Zheng, J., Zuo, Z., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03188-9 · Cited by 5
Chen, S., Lo, C., Liu, Z., Wang, Q. K., Ning, K., Li, T., & Sun, Y. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae045 · Cited by 4
Perspectives on CRISPR Genome Editing to Prevent Prion Diseases in High-Risk Individuals
Medd, M. M., & Cao, Q. (2024) · Biomedicines · doi:10.3390/biomedicines12081725 · Cited by 4
How to Shift the Equilibrium of DNA Break Repair in Favor of Homologous Recombination
Averina, O. A., Kuznetsova, S. A., Permyakov, O. A., & Владимирович, С. П. (2024) · Molecular Biology · doi:10.1134/s0026893324700201 · Cited by 4
Rapid one-pot human single nucleotide polymorphism genotyping platform with Cas13a nuclease
Lei, R., & Liu, X. (2024) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2024.08.003 · Cited by 4
Hung, J. E., Brewer, R. A., Elbakr, L., Mollica, A., Forguson, G., Chan, W. S., & Ivakine, E. A. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102401 · Cited by 4
A catalog of gene editing sites and genetic variations in editing sites in model organisms
Yang, W., Zhu, J., & Jin, W. (2024) · BMC Genomics · doi:10.1186/s12864-024-11073-9 · Cited by 4
Kumar, N. (2025) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-025-00807-w · Cited by 4
CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
van Essen, M. J., Riepsaame, J., & Jacob, J. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0063 · Cited by 4
Sapozhnikov, D. M., & Szyf, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-29332-2 · Cited by 4
Tang, N., Wu, Z., Gao, Y., Chen, W., Wang, Z., Su, M., Ji, W., & Ji, Q. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00501 · Cited by 4
Genome editing to re-domesticate and accelerate use of barley crop wild relatives
Hanak, T., Janjić, J., Hay, F. R., & Brinch‐Pedersen, H. (2023) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2023.1331577 · Cited by 4
Crispr-Based Editing of Human Pluripotent Stem Cells for Disease Modeling
Chang, Y., Lan, F., Zhang, Y., & Ma, S. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10713-7 · Cited by 4
Esquerra‐Ruvira, B., Baquedano, I., Ruiz, R., Fernandez, A., Montoliu, L., & Mojica, F. J. M. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14266 · Cited by 4
Shuai, Y., Xu, A., Li, J., Han, Z., Ma, D., Duan, H., Wang, X., Jiang, L., Zhang, J., Tan, G., et al. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.07.012 · Cited by 4
Plant genome editing branches out
Hille, L. T., & Kleinstiver, B. P. (2021) · Nature Plants · doi:10.1038/s41477-020-00840-7 · Cited by 4
Self-citationSpoto, M., Fleming, E. S., Ondouah-Nzutchi, Y., Guan, C., & Oh, J. (2021) · Research Square · doi:10.21203/rs.3.rs-484119/v1 · Cited by 4
Wang, Q., Bian, X., Du, J., Lv, Y., Tao, L., & Xie, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.01.442224 · Cited by 4
A treasure trove of molecular scissors
Rousset, F., & Sorek, R. (2021) · Science · doi:10.1126/science.abm2239 · Cited by 4
Editorial: Genetic engineering in farm animals
Petersen, B. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1155201 · Cited by 4
How CRISPR Is Revolutionizing the Generation of New Models for Cancer ResearchPreprint
Rivera, F. J. S., & Dow, L. E. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041384 · Cited by 4
Enhanced Genome Editing Activity with Novel Chimeric ScCas9 Variants in Rice
Liang, Z., Wu, Y., Deng, S., Wei, S., Zhang, K., & Guo, Y. (2025) · Advanced Science · doi:10.1002/advs.202411549 · Cited by 3
RNA-DNA hybrid binding domain broadens the editing window of base editors
Yang, Y., Fu, Z., Deng, S., Wu, G., Wang, C., Luo, X., Kang, R., Chen, Y., Peng, C., Zhang, P., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.06.024 · Cited by 4
Han, R., Gao, X., Qi, Y., Lu, X. J., Wang, X., & Tang, X. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70088 · Cited by 3
Pathway crosstalk enables degradation of aromatic compounds in marine Roseobacter clade bacteria
Xu, H.-W., Wang, X., Wei, Y., Cao, Y., Wang, S., & Xia, P. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00978-25 · Cited by 3
Sun, J., Liu, K., Yao, S., Zhang, H., Wang, J., Wang, Y., Tian, R., Xi, Z., Tian, S., Wang, P., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.009 · Cited by 3
Anti-CRISPR protein AcrIIA5 can enhance the activity and security of prime editing
Chen, Q., Jiang, X., Yang, B., Deng, Z., & Sun, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-66237-2 · Cited by 3
Structure‐Guided Engineering of a Cas12i Nuclease Unlocks Near‐PAMless Genome Editing
Chen, Q., Gou, H., Xu, C., Wang, S., Zhang, H., Song, M., Wang, M., Ji, X., Wei, X., Tan, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.202516670 · Cited by 3
Visual marker–assisted gene editing of MLO confers powdery mildew resistance in Nicotiana alata
Liu, H.-Y., Huang, X.-Y., Jin-Wang, Zhang, Y., Li, J., Kong, L., Zhou, S.-P., Hu, Q., & Wang, W. (2026) · aBIOTECH · doi:10.1016/j.abiote.2026.100024 · Cited by 3
Xin, C., Xiang, G., Cao, S., Wang, Y., Yuan, S., Liu, X., Huo, Y., Sun, J., Wan, X., Liu, D., et al. (2026) · Genome biology · doi:10.1186/s13059-026-03949-8 · Cited by 4
Non-viral delivery of genome-editing tools for treatment of genetic disorders
Yang, J., Chen, Y., Chen, X., & Ping, Y. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.02.014 · Cited by 3
CRISPR-enhanced microalgae biosynthesis: a promising approach for future functional feed ingredients
Li, Z., Li, C., Liu, H., Wang, Y., Sun, Y., Hou, D., He, J., & Wu, S. (2026) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-026-01367-1 · Cited by 3
Prime editing: Emerging mechanisms, engineering innovations, and next-generation applications
Muhammad, W., Amjad, A., Liu, Y., Umar, A., Chen, K., Wang, X., & Xu, K. (2026) · BioDesign Research · doi:10.1016/j.bidere.2026.100073 · Cited by 3
Bourgeois, W., Rice, H. E., Wenge, D. V., Perner, F., Yue, H., Regalado, B. D., Wan, G., Schroeder, J. C., Sommerschield, A., Hatton, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72685-1 · Cited by 3
Xu, Z., Qiu, S., Tan, Y., Kuang, Y., Yang, C., Yan, F., Zhou, X., & Zhou, H. (2026) · Plant Communications · doi:10.1016/j.xplc.2026.101921 · Cited by 3
Liao, S., He, Y., Liu, G., Li, Y., Tang, X., Zheng, X., Qi, Y., Zhang, T., & Zhang, Y. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.05.046 · Cited by 3
Applications of genome editing technologies in the treatment of human diseases
Alshorman, J., Mehran, M. J., Tembo, K. M., Mostafavi, N., Bolideei, M., & Wang, Y. L. (2026) · Gene Therapy · doi:10.1038/s41434-026-00627-z · Cited by 3
Meeusen, B., Ambjørn, S. M., Veis, J., Riley, R. C., Vit, G., Brauer, B. L., Møller, M. H., Greiner, E. C., Chan, C. B., Schmoker, A. M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74262-y · Cited by 3
Engineered ADARs enable precision A-to-G base editing of DNA
Im, H. W., Jeong, B., Lee, Y., Oh, Y. E., Jung, C., Kim, Y. W., Kim, D. Y., Lee, S., Uhm, H., Kim, Y., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03223-z · Cited by 3
Developing small Cas9 hybrids using molecular modeling
Mangin, A., Dion, V., & Menzies, G. E. (2024) · Scientific Reports · doi:10.1038/s41598-024-68107-1 · Cited by 5
Development of the A&GBE base editor for efficiently generating abundant genetic variation in rice
Zhang, W., Xu, Y., Cui, J., Xue, Y., Zhang, L., Wu, W., Wang, C., & Zhang, H. (2024) · The Crop Journal · doi:10.1016/j.cj.2024.08.009 · Cited by 3
Direct cloning strategies for large genomic fragments: A review
Chen, Y., Cui, Y., Chen, X., Wang, J., Li, B., & Yuan, Y. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108494 · Cited by 3
Engineering of Peptide‐Inserted Base Editors with Enhanced Accuracy and Security
Chen, Q., Sun, Y., Yao, J., Lu, Y., Qiu, R., Zhou, F., Deng, Z., & Sun, Y. (2025) · Small · doi:10.1002/smll.202411583 · Cited by 3
Zhang, Y., Zou, W., Zhou, Y., Chen, J., Hu, Y., & Wu, F. (2025) · Genome biology · doi:10.1186/s13059-025-03521-w · Cited by 3
CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy
Lehnertz, B., Langouët, M., Corneau, S., MacRae, T., Joe, M., Schmidt, E. N., Spinella, J.-F., Mayotte, N., Moore, S., Tellechea, M. F., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.010 · Cited by 3
Editing Properties of Base Editors with SpCas9-NG in Discarded Human Tripronuclear Zygotes
Liu, X., Zhou, X., Li, G., Huang, S., Sun, W., Sun, Q., Li, L., Huang, X., Liu, J., & Wang, L. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0036 · Cited by 3
Wei, Y., Zhang, M., Hu, J. T., Zhou, Y., Xue, M., Yin, J., Liu, Y., Feng, H., Zhou, L., Li, Z., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac043 · Cited by 3
Making headway toward enduring changes: perspectives on breeding tree crops through genome editing
Pinto, R. T., Abeyratne, C. R., Paiva, L. V., & Benedito, V. A. (2023) · Tree Genetics & Genomes · doi:10.1007/s11295-022-01583-6 · Cited by 3
Cas9‐orthologue‐mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences
Li, M., Zhao, Y., Xue, X., Zhong, J., Lin, J., Zhou, J., Yu, W., Chen, J., & Qiao, Y. (2023) · Biotechnology Journal · doi:10.1002/biot.202200533 · Cited by 3
The Application of CRISPR-Cas System in Glioblastoma Research and Treatment
Feng, J. (2023) · BIO Web of Conferences · doi:10.1051/bioconf/20236001011 · Cited by 3
Characterization of CoCas9 nuclease from Capnocytophaga ochracea
Vasileva, A., Selkova, P., Arseniev, A. S., Abramova, M., Shcheglova, N., Musharova, O. S., Мизгирев, И. В., Артамонова, Т. О., Khodorkovskii, M. A., Severinov, K., et al. (2023) · RNA Biology · doi:10.1080/15476286.2023.2256578 · Cited by 3
An SpG-Cas9-based cytosine base editor expands the scope of genome editing in carrot plants
Yarra, R., & Krysan, P. J. (2024) · Plant Cell Reports · doi:10.1007/s00299-024-03173-3 · Cited by 3
HyCas9-12aGEP: an efficient genome editing platform for Corynebacterium glutamicum
Zhang, F., Wang, J., Li, C.-L., & Zhang, W.-G. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1327172 · Cited by 3
Enhanced genome editing with a Streptococcus equinus Cas9
Liu, J., Wang, Y., Wei, J., Wang, S., Li, M., Huang, Z., Zhang, S., Liu, H., Huang, J., & Wang, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-07593-z · Cited by 3
Molecular tools for genome editing in plants: a synthetic overview
da Cunha, N. B., Leite, M. L., Rodrigues, J. C. M., Carrijo, J., Costa, F. F., Dias, S. C., Rech, E. L., & Vianna, G. R. (2025) · Vegetable Research · doi:10.48130/vegres-0025-0005 · Cited by 3
DUT (p.Y116C)-Mutation-Induced Thrombocytopenia in Rabbits
Fang, M., Yang, S., Liu, R., Wu, X., Jiang, L., Yang, J., Liu, X., Wang, G., Mu, C., Wang, X., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094169 · Cited by 3
Induced mutagenesis in wheat: from ionizing radiation to site-specific gene editing
Kishchenko, O., Stepanenko, A., & Borisjuk, N. V. (2021) · Fiziologia rastenij i genetika · doi:10.15407/frg2021.01.029 · Cited by 3
Highly Multiplexed Analysis of CRISPR Genome Editing Outcomes in Mammalian Cells
Ishiguro, S., & Yachie, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1441-9_12 · Cited by 3
Can SpRY recognize any PAM in human cells?
Ye, J., Xi, H., Chen, Y., Chen, Q., Lu, X., Lv, J., Chen, Y., Gu, F., & Zhao, J. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2100710 · Cited by 3
Gene therapy of brain cancer by drug delivery nanocapsules
Zhou, X., Wang, R., Sun, W., & Bonnet, S. (2022) · Matter · doi:10.1016/j.matt.2022.06.038 · Cited by 3
Contribution of CRISPRable DNA to human complex traits
Zhai, R., Zheng, C., Yang, Z., Li, T., Chen, J., & Shen, X. (2022) · Communications Biology · doi:10.1038/s42003-022-03969-7 · Cited by 3
Methods and Techniques to Select Efficient Guides for CRISPR-Mediated Genome Editing in Plants
D’Orso, F., Forte, V., Baima, S., Possenti, M., Palma, D., & Morelli, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-46150-7_6 · Cited by 3
Advances in engineering and synthetic biology toward improved therapeutic immune cells
Mai, D., Sheppard, N. C., & Levine, B. L. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100342 · Cited by 3
Plant Genome Editing: Advances and Prospects of Market‐Ready Food Crops
Heynes, X., Wang, D., & Lu, C. (2022) · Wiley eBooks · doi:10.1002/9781119312994.apr0799 · Cited by 3
High-efficiency HDR in immortalized cell lines by crude rAAV mediated donor template deliveryPreprint
Mehta, S., Buyanbat, A., Zheng, G., Liu, N., & Orkin, S. H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.02.490359 · Cited by 3
Engineered PAM-flexible FnCas9 variants for robust and specific genome editing and diagnosticsPreprint
Acharya, S., Ansari, A. H., Hirano, S., Paul, D., Rauthan, R., Kumar, M., Phutela, R., Sarkar, S., Gulati, S., Mahato, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-990232/v2 · Cited by 3
Engineered CRISPR-Base Editors as a Permanent Treatment for Familial DysautonomiaPreprint
Yun, S., Chekuri, A. K., Art, J., Kondabolu, K., Pokharel, S., Pigini, P., Dymock, S., Rufino-Ramos, D., Slaugenhaupt, S. A., Zeltner, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.27.625322 · Cited by 3
Self-citationShen, J., Aregawi, K., Anwar, S., Miller, T. I., Groover, E. D., Rajkumar, M., Savage, D. F., & Lemaux, P. G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.21.634149 · Cited by 3
Eaton, E. J., Wick, B. J., Chacón, J. S., Wang, A. J., Kluesner, M., Barnes, J. T., Kar, B., Wang, M., Johnson, M. J., Skeate, J. G., et al. (2026) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2026.102908 · Cited by 2
“Throughout this manuscript, we number the positions of the gRNA sequence 1–20 with 20 being closest to the PAM.”
Omura, S. N., Nakagawa, R., Kajimoto, S., Okazaki, S., Ishiguro, S., Mori, H., Onishi, K., Kashiwakura, Y., Hiramoto, T., Horinaka, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71626-2 · Cited by 2
Therapeutic Potential of CRISPR/Cas in Hashimoto's Thyroiditis: A Comprehensive Review
Upreti, A., & Mukherjee, S. (2024) · Current Gene Therapy · doi:10.2174/0115665232266508231210154930 · Cited by 2
Advancing plant gene activation with CRISPR-Act3.0
Movahedi, A., Mu, Z., & Yang, L. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.01.008 · Cited by 2
Bacterial directed evolution of CRISPR base editors
Mach, R. Q., & Miller, S. M. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.003 · Cited by 2
BEstimate: a computational tool for the design and interpretation of CRISPR base editing experiments
Dinçer, C., Fussing, B., Garnett, M. J., & Coelho, M. A. (2026) · Genome biology · doi:10.1186/s13059-026-04077-z · Cited by 3
Loop engineering of AtCas9 for effective and broad genome editing
Zhang, Y., Huang, D.-C., Duan, M., Zhang, Y.-M., Huang, A.-H., Yin, H., & Zhang, Y. (2025) · Cell Insight · doi:10.1016/j.cellin.2025.100286 · Cited by 2
Dua, P. H., Simon, B. M. J., Marley, C. B. E., Feliciano, C. M., Watry, H. L., Cowan, Q. T., Steury, D., Abraham, A., Gilbertson, E. N., Ramey, G. D., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.026 · Cited by 2
LNP‐mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1
Zhang, D., Zheng, R., Chen, Z., Chen, X., Yang, L., Huo, Y., Zhao, Y., Huang, J., Zhang, D., Yin, S., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70533 · Cited by 2
Base editing of β 0 -thalassemia mutations as a therapeutic strategy for severe β-hemoglobinopathies
Hardouin, G., Martinucci, P., Scaramuzza, S., Antoniou, P., Corradi, F., Tachtsidi, A., Corre, G., Mombled, M., Chermont, J., Manceau, S., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adt8617 · Cited by 2
CRISPR-Cas9 Gene Editing in Aspergillus: From Pathogenesis to Metabolic Engineering
Hu, D., Zhao, R., Lin, Y., & Jiang, C. (2025) · Biology · doi:10.3390/biology15010053 · Cited by 2
A novel plasmid-based co-tethered transcription platform for high yield, high purity mRNA synthesis
Mala, P., Banerjee, R., Abek, A., Forster, J., Pinjari, A., Kulkarni, A. A., & Martin, C. T. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1355 · Cited by 2
High-efficiency TadA cytosine base editors for precise modelling of human disease variants
Qin, W., Lin, S., Zhang, Y., Huang, K., Petree, C., Varshney, P., & Varshney, G. K. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01607-1 · Cited by 2
Therapeutic adenine base editor with minimized off-target effects
Sun, Y., Yan, N., Hu, F., Lu, H., Zuo, Z., Zhou, C., & Zuo, E. (2026) · Protein & Cell · doi:10.1093/procel/pwag006 · Cited by 2
Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis
Kim, P. G., Hergott, C. A., Miller, A. P., Deik, A., Boileau, M., Bullock, K. H., Pierce, K. A., Choy, A. H., Shin, W., McConkey, M. E., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.01.006 · Cited by 3
CRISPR/Cas Gene Editing and Improvement of Abiotic Stress Tolerance in Cereals
Maharajan, T., Krishna, T. P. A., & Ceasar, S. A. (2026) · Sustainability Sciences in Asia and Africa · doi:10.1007/978-981-95-6722-5_6 · Cited by 2
Metadata
- Authors
- Walton, R. T., Christie, K. A., Whittaker, M. N., & Kleinstiver, B. P.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Corresponding author
- Kleinstiver, Benjamin P.
- Venue
- Science
- Published
- 2020-04-17
- Volume
- 368
- Issue
- 6488
- Pages
- 290-296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7297043
- OpenAlex
- W3013504322
- Semantic Scholar
- 84609b61a82a11e3122a81b5bdae20a2822e577b
- Cited by
- 1,233
- References
- 48
- Citations by year
- 2026: 157 · 2025: 200 · 2024: 190 · 2023: 213 · 2022: 203 · 2021: 177 · 2020: 93
- FWCI
- 56.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01-HL142494)
- National Cancer Institute (R00-CA218870)
- American Society of Gene and Cell Therapy
- Margaret Q. Landenberger Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- CRISPR/Cas9, SpCas9, SPG, SpRY, base editing, genome editing, human cells
- MeSH terms
- Protein Domains, Gene Editing, CRISPR-Associated Protein 9, Humans, Substrate Specificity, Mutagenesis, Gene Targeting, Genetic Predisposition to Disease, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review